P. Toby Coates
Royal Adelaide Hospital · 182 works · 5,580 citations · h-index 42
Top works
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
- VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Calcific Uremic Arteriolopathy: Advances in Pathogenesis and Treatment
- Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
- Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients
- Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients
- COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?
- Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease
- Anti-HLA Donor-Specific Antibodies Detected in Positive B-Cell Crossmatches by Luminex® Predict Late Graft Loss
- The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo
- Dendritic Cells, Tolerance Induction and Transplant Outcome
- Early experience with COVID-19 in kidney transplantation
- Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial
- Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
- Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand
- Review of Epstein–Barr virus and post‐transplant lymphoproliferative disorder post‐solid organ transplantation (Review Article)
- Pituitary involvement in Wegener’s granulomatosis
- Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer–Restricted CD4+ T Cells Infiltrate Islets in Type 1 Diabetes
- Multicenter Australian Trial of Islet Transplantation: Improving Accessibility and Outcomes
- Dendritic cells, T cell tolerance and therapy of adverse immune reactions
- Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation